Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carmine DeAngelis"'
Publikováno v:
Clean Technologies, Vol 5, Iss 1, Pp 94-115 (2023)
This paper aims to design and implement a robust wireless charging system that utilizes affordable materials and the principle of piezoelectricity to generate clean energy to allow the user to store the energy for later use. A wireless charging syste
Externí odkaz:
https://doaj.org/article/cddf88fc7b82434680284b1f13e9a614
Autor:
Alice Loo, Piotr Stepien, Avery S. Feit, David M. Sabatini, Johann Bergholz, Walter Michael, Monther Abu-Remaileh, Christopher Thomas Brain, Rinath Jeselsohn, Baishan Jiang, Deborah Butter, Michael D. Cameron, Carmine DeAngelis, Wojciech Michowski, Rachel Schiff, Deborah A. Dillon, Karolina Maria Nowak, Iga Stukan, Bojana Jovanovic, Jean J. Zhao, Tobias Otto, Nathanael S. Gray, Maria Ericsson, Anne Fassl, Piotr Sicinski, Ralph Tiedt, Myles Brown, Kornelia Polyak, Qing Sheng
Publikováno v:
Science Advances
This study presents strategies to render triple-negative breast cancers sensitive to CDK4/6 inhibitors.
Inhibitors of cyclin-dependent kinases CDK4 and CDK6 have been approved for treatment of hormone receptor–positive breast cancers. In contr
Inhibitors of cyclin-dependent kinases CDK4 and CDK6 have been approved for treatment of hormone receptor–positive breast cancers. In contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc4815f131efc64eea3d77fec1fe579f
http://hdl.handle.net/11588/857297
http://hdl.handle.net/11588/857297
Autor:
Jamunarani Veeraraghavan, Martin Shea, Mothaffar F. Rimawi, Vidyalakshmi Sethunath, Tamika Mitchell, Rachel Schiff, Susan G. Hilsenbeck, Resel Pereira, Lanfang Qin, Sarmistha Nanda, Kent Osborne, Carmine DeAngelis, Huizhong Hu
Publikováno v:
Cancer Research. 79:4757-4757
Background: Despite the advent of HER2-targeted therapies, including the monoclonal antibody trastuzumab (T) and the HER1/2 inhibitor lapatinib (L), for HER2+ breast cancer (BC), resistance still poses a major challenge. L and L+T resistant (R) HER2+
Publikováno v:
JAMA: The Journal of the American Medical Association. 191:1080
IN THE PAST ten years, over a quarter of a million patients have been admitted to five hospitals, at which medical records have been accessible to the authors (Professional Hospital and St. John's Riverside Hospital, both in Yonkers, NY; Bronx Vetera